Steven D Nathan

Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.

D. Montani, T. Corte, D. Kiely, 2023, The Lancet. Respiratory medicine.

Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension

P. Hassoun, O. Shlobin, L. Piccari, 2024, Pulmonary circulation.

Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial

T. Corte, Ganesh Raghu, Yoshikazu Inoue, 2024, American journal of respiratory and critical care medicine.

Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.

Jonathan H. Chung, D. Lynch, F. Martinez, 2019, The Lancet. Respiratory medicine.